The pharmaceutical industry won big on Tuesday after California voters rejected a ballot referendum that would have capped drug prices for certain state programs.
California voters reject Proposition 61, which would have forced drug companies to offer products for state healthcare programs at the same price paid by the U.S. Department of Veterans Affairs, which negotiates with drug makers for lower prices.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.